Rating History for Sage Therapeutics (SAGE) by Guggenheim

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/2/2021 Yatin Suneja Upgrade Buy
(Neutral)
55.00
(N/A)
42.37
(32.28)
-23.81% Details